Industries
What We Do
Advisory firm for global companies evaluating the cannabis industry post-rescheduling. 4+ years of proven track record with dozens of successful client engagements.
Who it's for
This isn't for everyone. That's the point.
Tobacco Companies
Tracking the shift in federal policy as it relates to your existing product portfolio and potential product line extensions into cannabis-adjacent categories.
Alcohol Companies
Watching cannabis beverages as a category with genuine interest — and recognizing you don't know what you don't know about this space.
Consumer Packaged Goods (CPG)
Considering adding hemp or cannabis-derived products to an existing portfolio. Looking for the angle that won't poison your existing brand relationships.
Biotech Firms
Exploring cannabis-derived drug development or CBD-based therapeutic applications. The regulatory pathway here is different from consumer products — and far more complex.
Pharmaceutical Companies
Evaluating whether to enter the cannabinoid pharmaceutical space and what pathway makes sense for your pipeline and regulatory posture.
We Have Been In Your Seat
We have been CEO's, raised capital for, acquired, owned, or started companies in these industries.
